Project - Anti-cancer High Jewelry
Like a master jeweler who meticulously sets each stone to enhance the brilliance of a jewel, our project leader is... View Article
Archives
Project - Domino Effect
Our project leaders are developing a treatment that blocks an enzyme (ELP3), crucial for the growth and resistance of cancer... View Article
Project - Light the Fire
The Foundation is supporting the development of an immune system stimulant which is showing very promising cure rates, particularly for... View Article
Project - Tobacco to cure cancer
Our laureate atb therapeutics, based near Marche-en-Famenne (B), has developed a new class of cancer drugs from tobacco derived plants:... View Article
Project - Chasing the clouds
Cancer’s number one enemy is our immune system, whose mission is to detect and eliminate cells that are functioning abnormally.... View Article
Project - The cloak of invisibility
Mablink Bioscience is developing a new generation of anti-cancer “missiles” that are up to 10 x more effective thanks to... View Article
Project - Paediatric neuroblastoma
Neuroblastoma is a tumour of the peripheral nervous system with an incidence of 1 per 100,000 children. It carries one... View Article
Project - The Trojan llama
Precirix (formerly Camel-IDS) is a biotech company located in Jette (B) that was founded in 2014 as part of the... View Article
Project - Cancer cell genome sequencing
Biogazelle is a Contract Research Organisation (CRO) renowned for its expertise in sequencing. This satellite of the University of Ghent,... View Article
Project - Liver cancer
Hepatocellular carcinoma is one of the deadliest forms of cancer. 600 new cases are diagnosed in Belgium every year. Its... View Article
Project - Enhanced data analysis
DNAlytics’ core business is carrying out statistical analyses of client-generated data (from any player in the healthcare sector) in order... View Article
Project - Kidney cancer
Renal cell carcinoma (RCC) is the most common form of kidney cancer, representing 90% to 95% of all cases. It... View Article